Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2025: USD 575.71 M

Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 575.71 M for the Trailing 12 Months (TTM) ending June 30, 2025, a 16.29% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 495.06 M, a 25.32% change year over year.
  • Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 395.04 M, a 56.60% change year over year.
  • Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 252.26 M, a 55.29% change year over year.
  • Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 162.44 M, a 52.30% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue